Heterozygous overexpression of preproendothelin-1 in endothelial cells enhances thromboxane-prostanoid receptor-induced contractions in the renal artery of obese mice by Xu, A et al.
Title
Heterozygous overexpression of preproendothelin-1 in
endothelial cells enhances thromboxane-prostanoid receptor-
induced contractions in the renal artery of obese mice
Author(s) Baretella, OM; Chung, SK; Xu, A; Vanhoutte, PM
Citation
The 13th International Conference on Endothelin (ET-13), Tokyo,
Japan, 8-11 September 2013. In ET-13 Program & Abstracts,
2013, p. 53, abstract O-5
Issued Date 2013
URL http://hdl.handle.net/10722/203720
Rights Creative Commons: Attribution 3.0 Hong Kong License
- 53 -
Celebrating 25 Years of the Discovery of ENDOTHELIN
D
AY
 1
O-5
Heterozygous Overexpression of Preproendothelin-1 in Endothelial Cells Enhances Thromboxane-Prostanoid 
Receptor-Induced Contractions in the Renal Artery of Obese Mice
Oliver Baretella1, Sookja K. Chung2,4, Aimin Xu1,3,4, Paul M. Vanhoutte1,4
1Department of Pharmacology & Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China, 2Department of 
Anatomy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China, 3Department of Medicine, Li Ka Shing Faculty of 
Medicine, The University of Hong Kong, Hong Kong, China, 4Research Centre of Heart, Brain, Hormone & Healthy Aging, Li Ka Shing Faculty of 
Medicine, The University of Hong Kong, Hong Kong, China
Circulating levels of the endothelium-derived peptide endothelin-1 (ET-1) are elevated in human obesity, and ET-1 mediated vascular 
tone is increased. The renal artery is important in controlling intrarenal blood # ow and is highly sensitive to ET-1. Whether or not ET-1 
a" ects renal artery tone in obesity is unknown. To investigate the role of endogenous ET-1, a mouse model with tie-1 promoter-driven 
endothelium-restricted heterozygous overexpression of preproendothelin-1 was used (TET+/-). Obesity was induced in TET+/- and WT 
littermates by feeding a high fat diet for seven months; lean controls were kept on standard chow. The main renal arteries were studied 
in wire myographs testing contractions (in the presence of L-NAME) to ET-1, serotonin (5-HT), and U46619, targeting ETA, 5-HT2, and TP 
receptors, respectively. Contractions to ET-1 were comparable between groups (PD2 8.29±0.05, n=6-8); 5-HT-induced responses were 
facilitated at lower concentrations in obese mice leading to a shift in PD2 (lean 7.08±0.02 vs. obese 7.23±0.07, n=5-8, P<0.01). Responses 
to U46619 were signi! cantly shifted to the left in renal arteries of obese animals (PD2 8.57±0.06 vs. lean 8.21±0.05, n=5-8, P<0.001), and 
the area under the curve was signi! cantly di" erent between lean and obese TET+/- mice (AUC 418±23 vs. lean 319±25, n=5, P<0.05). 
Thus, TET+/- had no e" ect on responses in lean animals. By contrast, in obesity heterozygous overexpression of ppET-1 enhanced TXA2-
mediated, but not 5-HT or ET-1 induced contractions of the renal artery.
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The E! ect of Proteinuria-Mediated Endothelin-1 Downregulation of PKCα Signalling in Proximal Tubular Cells 
and Its Successul Treatment is Measurable Using microRNA15a as Biomarker in Vitro and in Vivo
Heike Loeser1, Melanie von Brandenstein1, Maike Wittersheim1, Volker Burst2, Claudia Richter1, Bernd Hoppe3, Jochen W.U. Fries1
1Institute of Pathology, University Hospital Cologne, Cologne, Germany, 2Department of Internal Medicine II, Division of Nephrology, University 
Hospital Cologne, Cologne, Germany, 3Institute of Pediatrics, Division of Nephrology, University Hospital Cologne, Cologne, Germany
In proteinuric diseases, stimulation of proximal tubule cells (RPTECs) by protein and endothelin-1 result in the activation of di" erent 
signal pathways, ultimately causing renal insufficiency. Therapeutic interventions are hampered by the lack of specific and easily 
detectable markers. We described a regulatory pathway in which nuclear migration of protein kinase C α controls the release of pri-
miRNA15a. After endothelin-1 stimulation the migration of PKCα is inhibited, and mature miRNA15a is made. Using qRT-PCR we detect 
miRNA15a in the urine of adult and pediatric patients with membranous or mimimal change nephropathy. By laser-microdissection 
this miRNA is predominantly located in the proximal tubules. In cell culture, human RPTECs produce the highest miRNA15a levels after 
ET-1 stimulation. In rats after 5/6 nephrectomy, miRNA15a is increased in the urine. By graded sieving and qRT-PCR, the highest amount 
of miRNA15a is found in the tubular fraction. Selegiline treatment upregulates PKCα in vitro and in the murine adriamycin model, 
signi! cantly downregulating ET-1 induced miRNA15a production. Thus measuring urinary miRNA15a levels: i) indicates the regulation of 
a signal pathway in RPTECs in vivo in proteinuric conditions; ii) allows for the ! rst time to control the e" ectiveness of a therapy aiming to 
protect proximal tubules. 
